Working… Menu
Trial record 1 of 5 for:    dnx | Glioblastoma
Previous Study | Return to List | Next Study

DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03714334
Recruitment Status : Recruiting
First Posted : October 22, 2018
Last Update Posted : June 25, 2020
DNAtrix, Inc.
Information provided by (Responsible Party):
Clinica Universidad de Navarra, Universidad de Navarra

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 16, 2022
Estimated Study Completion Date : October 16, 2022